Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Poet who wrote (4125)	1/13/1999 1:35:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 56532

re Post on biotechs my pleasure--you see I had seen a Lehman report last fall giving a list of small and micro cap biotechs which were trading near book...and so perhaps a bargain. One stock on that list which caught my eye was hysq. Back in November Popular Science did an article on gene chip technology, the article summarized work being done by Affymetrix, the Argonne National Laboratory with Russian Academy of Science, Hyseq, Incyte Pharmaceuticals, Nanogen, and the Oak Ridge National Laboratory. It is a good one to keep in the back of your head in case you're at the library and need something to read. My guess is that INCY and AFFX are running away with things ...you may remember seeing claims from Hyseq...and recently by Curagen: biz.yahoo.com (CuraGen Announces Discovery of over 60,000 cSNPs) ...well, these two stocks in particular have not done too much lately, in fact about the only thing you will see in the crgn stock price is a quick spike on that polymorphism PR. Gettin back to hysq...note that the "Affymetrix sued by Hyseq" thread has been quiet since September, and the regular HYSQ thread is pretty quiet too--the last message on there worth reading is linked here: Message 5834505 and another post to read from the Dr. Message 4874891 Still, I'm keeping an eye on these guys, affx and incy don't fit the type of investment I like right now (dirt cheap) but if we saw a big correction in the market in general, I'd probably shop there instead of the others I've given. I may change my mind about hysq or crgn, but nobody has convinced me yet, and I just sorta decided to ignore this subsector of biotech...and it seems that lately everybody is getting into the act, PKN, Hoechst and the big cap bios of course too...bioinformatics is the keyword if you want to do word searches etc. Next topic...H&Q Wednesday, these are the symbols I'll probaby watch...see if they do anything after presentations: IMNX, TGEN, SUGN, GZTC, ELN--that list could be longer, but these are the only things that interest me. There was not much action on after today's presentations however...glfd was the only one of which I had a mental note to watch that rallied a bit...so I am not expecting too much on Wednesday. --MM